Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Dimethaid Research announces encouraging results with its immunomodulator

May 31, 1996

Meningococcal protein with vaccine potential

May 31, 1996

Ruthenium complexes revealed by Procept

May 31, 1996

Merck's pediatric pneumococcal conjugate vaccine in advanced trials

May 24, 1996

HPV vaccine in phase I at Merck & Co.

May 24, 1996

New finding may help in overcoming bacterial resistance

May 17, 1996

SKB and MicroCarb to collaborate on bacterial vaccines

May 17, 1996

Vical, Pasteur Merieux Connaught expand naked DNA vaccine collaboration

May 17, 1996

IMP dehydrogenase inhibitor synthesized at Roche Bioscience

May 17, 1996

CD45RB for organ transplant rejection

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...